Pantoprazole recalls
The FDA has published 18 recalls involving Pantoprazole since 2013. The latest was reported on 29 Apr 2026. Most were for manufacturing (cgmp) deviations. Jubilant Cadista Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls18since 2013
Last 12 months1reported
Class I16% of total
Ongoing2latest 29 Apr 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 6%Class II 14 78%Class III 3 17%
Why pantoprazole is recalled
Companies
Brands
By year
Ongoing pantoprazole recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg recalledPantoprazole Sodium | Hetero Labs Limited (Unit V) | Other | Nationwide |
| Drug | CLASS II | Pantoprazole Sodium Delayed Release Tablets USP 40mg recalledPantoprazole Sodium | Hetero USA | Manufacturing (CGMP) Deviations | Nationwide |
All pantoprazole recalls, newest first
18 totalShould you stop taking Pantoprazole?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.